Chungmu Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT01984931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

International Education Center of Shoulder, Elbow Surgery: Chungmu Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

metoclopramide (reglan) (1 trial)

trimebutine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nausea (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2